Eravacycline Combination Therapy for MRAB

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

January 26, 2024

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2024

Conditions
Pulmonary InfectionPneumonia, BacterialAcinetobacter Baumannii
Interventions
DRUG

Eravacycline Injection

Eravacycline at the recommended dose and administration method according to the instructions: 1 mg/kg intravenous administration, every 12 hours. The intravenous infusion duration is approximately 60 minutes. For patients with severe liver impairment (Child-Pugh class C), administer 1 mg/kg of this product every 12 hours on the first day, followed by 1 mg/kg every 24 hours starting from the second day.

Trial Locations (1)

350000

RECRUITING

Fujian Medical University Union hospital, Fuzhou

All Listed Sponsors
lead

Fujian Medical University Union Hospital

OTHER